Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/03/2007EP1838698A1 Pyrimidine derivatives as gpcr agonists
10/03/2007EP1838696A1 Novel cyanoguanidine compounds
10/03/2007EP1838694A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
10/03/2007EP1838690A2 Compounds with kv4 ion channel activity
10/03/2007EP1838687A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838686A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838685A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838684A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838680A2 Macrocyclic compounds and compositions useful as bace inhibitors
10/03/2007EP1838679A1 Imidazole derivatives as enzyme reverse transcriptase modulators
10/03/2007EP1838677A2 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
10/03/2007EP1838675A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
10/03/2007EP1838674A2 Heteroaryl sulfonamides and ccr2
10/03/2007EP1838672A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders
10/03/2007EP1838670A1 Process for the preparation of carvedilol and its enantiomers
10/03/2007EP1838669A1 Indoles useful in the treatment of inflammation
10/03/2007EP1838667A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
10/03/2007EP1838665A1 Mutilin derivatives and their use as pharmaceutical
10/03/2007EP1838663A1 Glycine transport inhibitors
10/03/2007EP1838662A1 Squaric acid derivatives
10/03/2007EP1838655A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
10/03/2007EP1838392A2 Selenium-containing medicaments for the prevention or treatment of endothelial vascular diseases
10/03/2007EP1838355A1 Improved quenching methods for red blood cell inactivation process
10/03/2007EP1838352A2 Methods and compositions for modulating keratinocyte function
10/03/2007EP1838351A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/03/2007EP1838347A1 Pharmaceutical compositions for treating diseases associated with nf-kappab activity
10/03/2007EP1838335A1 Growth factor composition
10/03/2007EP1838330A1 Treatment of solid cancers
10/03/2007EP1838326A1 Process for producing polypeptide mixtures using hydrogenolysis
10/03/2007EP1838325A1 NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f][1,4]THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS
10/03/2007EP1838324A2 Novel farnesyl protein transferase inhibitors and their use to treat cancer
10/03/2007EP1838323A2 Cardiovascular compositions
10/03/2007EP1838322A2 Use of purine derivatives as hsp90 protein inhibitors and for treatment of cancer
10/03/2007EP1838321A2 Cxcr4 antagonists for the treatment of hiv infection
10/03/2007EP1838320A2 Cxcr4 antagonists for the treatment of medical disorders
10/03/2007EP1838319A2 Pde5 inhibitor compositions and methods for immunotherapy
10/03/2007EP1838318A1 Use of oxycodone for treating visceral pain
10/03/2007EP1838317A1 Analgesic conjugates
10/03/2007EP1838316A2 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
10/03/2007EP1838315A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
10/03/2007EP1838314A1 Process for preparing lansoprazole
10/03/2007EP1838313A2 Pharmaceutical composition comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus
10/03/2007EP1838312A2 Chemical compounds
10/03/2007EP1838311A1 G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
10/03/2007EP1838310A1 Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders
10/03/2007EP1838309A1 Chromane derivatives useful as acid pump antagonists
10/03/2007EP1838308A1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
10/03/2007EP1838307A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers
10/03/2007EP1838306A1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
10/03/2007EP1838305A1 Radiosensitizer formulations comprising nitrohistidine derivatives
10/03/2007EP1838304A2 Heterocyclic aspartyl protease inhibitors
10/03/2007EP1838303A2 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
10/03/2007EP1838302A2 Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same
10/03/2007EP1838301A1 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
10/03/2007EP1838300A2 2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
10/03/2007EP1838299A1 Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate
10/03/2007EP1838298A2 Stilbene derivatives and their use for binding and imaging amyloid plaques
10/03/2007EP1838297A1 1-aminocyclohexane-derivatives for the treatment of multiple sclerosis emotional lability and pseudobulbar affect
10/03/2007EP1838296A2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
10/03/2007EP1838295A1 Anthelmintic composition
10/03/2007EP1838294A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation
10/03/2007EP1838291A2 Pharmaceutical formulations and methods of use
10/03/2007EP1838288A1 Therapeutic materials and methods
10/03/2007EP1838287A1 Process for preparing granulates comprising amoxicillin
10/03/2007EP1838172A1 Novel nutraceutical compositions
10/03/2007EP1838152A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
10/03/2007EP1758900B1 Substituted tricyclic benzimidazoles
10/03/2007EP1751157B1 Inhibitors of the hiv integrase enzyme
10/03/2007EP1747777A4 Medicinal agent
10/03/2007EP1740214B1 Method of stabilizing disordered cefovecin sodium salt
10/03/2007EP1737465A4 Composition and method of decreasing renal ischemic damage
10/03/2007EP1730159B1 Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same
10/03/2007EP1699451B1 Use of silibinin together with alpha-liponic acid for the treatment of chronic obstructive pulmonary diseases
10/03/2007EP1663232B1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
10/03/2007EP1648906B1 Organosilicon compounds and their use
10/03/2007EP1622874B1 3,4-dihydro-1h-quinolin-2-one derivatives as norepinephrine reuptake inhibitors
10/03/2007EP1622660A4 Novel methods for administration of drugs and devices useful thereof
10/03/2007EP1615908B1 Basic salt of thioctic acid with l-carnitine
10/03/2007EP1613298A4 Lysophosphatidic acid analogs and inhibition of neointima formation
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/03/2007EP1589976B1 Use of a combination of an aromatase inhibitor, a progestin and an oestrogen for the treatment of endometriosis
10/03/2007EP1583756B1 Thiophene carboxamides as inhibitors of the enzyme ikk-2
10/03/2007EP1575598B1 Pharmaceutical compositions comprising a combination of calcitriol and clobetasol propionate
10/03/2007EP1558219B1 Pharmaceutical formulation of olanzapine
10/03/2007EP1549638B1 Indole-3-carboxamides as glucokinase (gk) activators
10/03/2007EP1530461B1 Transdermal administration of (r)-3,3-diphenylpropylamine monoesters
10/03/2007EP1529044B1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/03/2007EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
10/03/2007EP1501548A4 Chemically activated carboxypolysaccharides and uses
10/03/2007EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/03/2007EP1463493B1 Methods of inducing ovulation-using a non-polypeptide camp level modulator
10/03/2007EP1456180B1 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use
10/03/2007EP1448530B1 Heteroaryl carboxylic acid amides
10/03/2007EP1439828A4 Veterinaire florfenicol formulation that is syringeable under cold weather conditions
10/03/2007EP1436011B1 Dendrimers for use in targeted delivery
10/03/2007EP1418921B1 Anti-tumour 2-alkoxyestradiol sulfamates
10/03/2007EP1414828B1 Antitumoral analogs
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1362855B1 Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
1 ... 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 3576 3577 3578 3579 3580 ... 7860